Bird Rock Bio is developing novel, best-in-class biologic therapeutics, specifically antibodies, to treat large populations with huge unmet medical needs. We are bringing the next era of biologic technologies with improved efficacy as well as affordable access to care.
In order to be truly game changing, healthcare needs innovation.
Our drug development is focused on validated targets that could address significant medical need in unique and emerging markets, both geographically and scientifically.
Bird Rock Bio’s novel antibody discovery platform (intramembranous Confirmation Antigen Presenting System or “iCAPS”) was developed internally under the direction of the company’s scientific founder Dr. Ray Stevens.